EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.

Mark Bower, E.S. Newlands, L. Holden, +5

Journal of Clinical Oncology

Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000

Iain A. McNeish, Sarah Strickland, L. Holden, +4

Journal of Clinical Oncology

Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic Tumors

E.S. Newlands, Paul Mulholland, L. Holden, +2

Journal of Clinical Oncology

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors.

G.J.S. Rustin, E.S. Newlands, Jean Michel Lutz, +6

Journal of Clinical Oncology

Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989

E.S. Newlands, K. D. Bagshawe, Richard H. J. Beǵent, +2

BJOG An International Journal of Obstetrics & Gynaecology

Developments in chemotherapy for medium‐ and high‐risk patients with gestational trophoblastic tumours (1979–1984)

E.S. Newlands, K. D. Bagshawe, Richard H. J. Beǵent, +3

BJOG An International Journal of Obstetrics & Gynaecology

Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment

Nirupa Murugaesu, Peter Schmid, Gairin Dancey, +7

Journal of Clinical Oncology

Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome

Robert Woolas, Mark Bower, E.S. Newlands, +3

BJOG An International Journal of Obstetrics & Gynaecology

FertilityGestational Trophoblastic DiseaseReproductive HealthPathologyGynecology +16

Secondary tumours following etoposide containing therapy for germ cell cancer

Chris Boshoff, Richard H. J. Beǵent, R.T.D. Oliver, +6

Annals of Oncology

Endocrine OncologySecondary TumoursMalignant DiseaseMedicinePathology +4

Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy

Mark Bower, E.S. Newlands, L. Holden, +2

Annals of Oncology

UrologySurgical OncologyGenitourinary CancerMedicinePathology +5